Latest News

Cannabis constituent has no effect on multiple sclerosis progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis, shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Most published medical research is false; Here's how to improve

  • How troubled marriage, depression history promote obesity

  • Bogus recycling bins help identify drinking patterns among low-income seniors

  • Understanding drinking behaviors among women with unwanted pregnancies

  • Bar attendance supports heavy drinking by young adults in the US-Mexico border region

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Memory decline among menopausal women could be next research frontier for hypnotic relaxation therapy

  • Immersed in violence: How 3-D gaming affects video game players

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  •